European Companies Search Engine
Wordmark: “KISIMA“ Euipotm 3 May 2017 European Union Intellectual Property Office (Trade Marks)
History
Text
Trade mark
| Type | Word |
| Name | KISIMA |
| Filing number | 015306194 |
| Trade mark status | REGISTERED |
| Nice Classification |
1: Peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins, in particular for industrial and scientific purposes; biological, micro-biological and biochemical products for analyses in laboratories; diagnostic preparations containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific purposes; peptide substrates for scientific purposes; proteins for use in science, industry and manufacture; biological preparations; reagents containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific and research purposes; nucleic acids, in particular recombinant nucleic acids; nucleic acids for scientific purposes; nucleic acid sequences; biological active peptides; antisera for scientific and industrial purposes; all above other than for medical and veterinary use. 5: Proteins, peptides, modified peptides; proteins, derivatives of peptides and proteins as well as protein- and peptide-pools for medical and pharmaceutical purposes; diagnostic preparations; cells for medical purposes; pharmaceutical preparations and compositions for the treatment and prevention of cancer; recombinant nucleic acids for medical use; nucleic acids for medical purposes; nucleic acid sequences and proteins for medical and diagnostic purposes; kits containing proteins, peptides, modified peptides and proteins and derivatives of peptides and proteins as well as protein- and peptide-pools for medical purposes; all the aforementioned goods in the form of vaccines, and/or for use in the field of oncology, infectious diseases and/or autoimmune diseases, and/or for the treatment of and/or the prevention of cancer diseases, infectious diseases and/or autoimmune diseases. 42: Scientific and technological services and research and design relating thereto; Industrial analysis and research services; research and development services all relating to science; medical and pharmaceutical research and development services; biological and clinical research and development services; research and development services all relating to industry; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical, biochemical, medical or pharmaceutical research; medical and pharmacological research services; medical research; scientific research for medical purposes; laboratory research services in the field of protein, peptide and molecular biology; provision of information and data relating to medical and scientific research and development; medical and pharmaceutical product development and evaluation; Research and development services for the pharmaceutical industry; Information technology services for the pharmaceutical and healthcare industries. 44: Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services; Pharmaceutical services; Medical information. |
| Filing date | 06/04/2016 |
| Registration date | 28/04/2017 |
| Expiry date | 06/04/2036 |
| Owners |
CH-1205 Geneva Switzerland |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: AMAL THERAPEUTICS SA, Geneva, Switzerland.